A Look at a Very Silicon Valley Approach to Repopulation
On Uncanny Valley this week, our hosts talk about the pronatalism movement, and how the push to increase birth rates is trending among some of Silicon Valley’s biggest and wealthiest…
wired business
If Ukraine Loses Starlink, Here Are the Best Alternatives
OneWeb, Project Kuiper, and IRIS2 could all, in time, replace Elon Musk’s satellite communications system in Ukraine, but they will struggle to replicate Starlink’s coverage and usability.
Chatbots, Like the Rest of Us, Just Want to Be Loved
A study reveals that large language models recognize when they are being studied and change their behavior to seem more likable.
Airplanes of the Future Could Be Fitted with Feather-Like Flaps
Research suggests that free-moving panels on aircraft wings can improve stability, reduce turbulence, and add fuel efficiency.
Pioneers of Reinforcement Learning Win the Turing Award
Having machines learn from experience was once considered a dead end. It’s now critical to artificial intelligence, and work in the field has won two men the highest honor in…
How Trump’s Tariffs Will Disrupt Key Industries in Mexico
The imposition of tariffs on Mexico and Canada represents a violation of the USMCA and could trigger a tariff war, experts say.
Trump Still Considering Tariffs on Taiwanese Chips, Despite $100 Billion TSMC Deal
Enforcing the tariffs on Taiwan would be difficult, and they wouldn’t necessarily be enough to meaningfully increase semiconductor manufacturing in the United States, experts told WIRED.
Some DOGE Staffers Are Drawing Six-Figure Government Salaries
Engineers and executives at the so-called Department of Government Efficiency are drawing healthy taxpayer-funded salaries—sometimes from the very agencies they are cutting.
Donald Trump’s Not-So-Strategic Crypto Reserve
When US president Donald Trump picked out a handful of cryptocurrencies for potential inclusion in a national strategic reserve, he sparked a trading frenzy—and questions about who stands to benefit.
Trump’s FDA Cuts Are Putting Drug Development at Risk
New SEC filings from pharmaceutical companies reveal Donald Trump and Elon Musk’s cost-cutting measures could slow drug research and delay FDA approvals.